A review of the role of enhanced apoptosis in the pathophysiology of cystinosis

Molecular Genetics and Metabolism

Volumn 92, Issue 4, 2007, Pages 292-298

  Thoene, Jess G ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Apoptosis; Atubular glomeruli; Cysteinylation; Cystinosis; Cystinosis variants; Modifier genes; PKC ; Swan neck deformity

Indexed keywords

CYSTINE; DISULFIDE;

APOPTOSIS; CELL LOSS; CELL MEMBRANE PERMEABILITY; CELL METABOLISM; CYSTINOSIS; EPITHELIUM CELL; FIBROBLAST CULTURE; GLOMERULUS; HUMAN; KIDNEY FAILURE; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; LYSOSOME; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

APOPTOSIS; CELLS, CULTURED; CYSTINE; CYSTINOSIS; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; KIDNEY DISEASES; KIDNEY TUBULES; KIDNEY TUBULES, PROXIMAL; LYSOSOMES; PROTEIN KINASE C-DELTA;

EID: 36148938793     PISSN: 10967192     EISSN: 10967206     Source Type: Journal    
DOI: 10.1016/j.ymgme.2007.07.008     Document Type: Review

References (41)

1. Gahl W.A., Thoene J., and Schneider J. Cystinosis: A disorder of lysosomal membrane transport. In: Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. eight ed. (2001), McGraw Hill 5085-5108
2. Palacin M., Goodyear P., and Nunes V. Gasparini. In: Cystinuria P., Scriver C., Beaudet A., Sly W., and Valle D. (Eds). The Metabolic and Molecular Bases of Inherited Disease. eight ed. (2001), McGraw Hill 4909-4932
3. Town M., Cherqui S., Attard M., Forestier L., Whitmore S.A., Callen D.F., Gribouval O., Broyer M., Bates G.P., van't Hoff W., and Antignac C. A novel gene encoding an integral membrane protein is mutated in nephropathic cystinosis. Nature Genet. 18 (1998) 319-324
4. Thoene J., Oshima R., Crawhall J., Olson D., and Schneider J. Cystinosis: Intracellular cystine depletion by aminothiols in vitro and in vivo. J. Clin. Invest. 58 (1976) 180-189
5. Shotelersuk V., Larson D., Anikster Y., McDowell G., Lemons R., Bernardini I., Guo J., Thoene J., and Gahl W. CTNS mutations in an American-based population of cystinosis patients. Am. J. Human Genet. 63 (1998) 1352-1362
6. Patrick A. Deficiencies of -SH-dependent enzymes in cystinosis. J. Clin. Pathol. 28 (1965) 427-443
7. Thoene J., Lemons R., Anikster Y., Mullet J., Paelicke K., Lucero C., Gahl W., Schneider J., Shu S.G., and Campbell H.T. Mutations of CTNS causing intermediate cystinosis. Mol. Genet. Metab. 67 (1999) 283-293
8. Anikster Y., Lucero C., Guo J., Huizing M., Shotelersuk V., Bernardini I., McDowell G., Iwata F., Kaiser-Kupfer M.I., Jaffe R., Thoene J., Schneider J.A., and Gahl W.A. Ocular Nonnephropathic Cystinosis: Clinical, Biochemical, and Molecular Correlations. Pediatr. Res. 47 (2000) 17-23
9. Attard M., Jean G., Forestier L., Cherqui S., van′t Hoff W., Broyer M., Antignac C., and Town M. Severity of phenotype in cystinosis varies with mutations in the CTNS gene: predicted effect on the model of cystinosin. Hum. Mol. Gen. 8 (1999) 2507-2514
10. Kalatzis V., Nevo N., Cherqui S., Gasnier B., and Antignac C. Molecular pathogenesis of cystinosis: Effect of CTNS mutations on the transport activity and subcellular localization of cystinosin. Hum. Mol. Gen. 13 (2004) 1361-1371
11. Baum M. The Fanconi syndrome of cystinosis: Insights into the pathophysiology. Pediatr. Nephrol. 12 (1998) 492-497
12. Levtchenko N., Wilmer M., Janssen A., Koenderink J., Visch H., Willems P., de Graaf-Hess A., Blom H., van den Heuvel L., and Monnens L. Decreased intracellular ATP content and intact mitochondrial energy generating capacity in human cystinotic fibroblasts. Pediatr. Res. 59 (2006) 287-292
13. Wilmer M., de Graaf-Hess A., Blom H., Dijkman H., Monnens L., van den Heuvel L., and Levtchenko E. Elevated oxidized glutathione in cystinotic proximal tubular epithelial cells. Biochem. Biophys. Res. Commun. 337 (2005) 610-614
14. Laube G., Shah V., Stewart V., Hargreaves I., Haq M., Heales S., and van′t Hoff W. Glutathione depletion and increased apoptosis rate in human cystinotic proximal tubular cells. Pediatr. Nephrol. 21 (2006) 503-509
15. Oshima R., Rhead W., Thoene J., and Schneider J. Cystine metabolism in human fibroblasts. J. Biol. Chem. 251 (1976) 4287-4293
16. Levtchenko E., de Graaf-Hess A., Wilmer M., van den Heuvel L., Monnens L., and Blom H. Altered status of glutathione and its metabolites in cystinotic cells. Nephrol. Dial Transplant. 20 (2005) 1828-1832
17. Oude Elferink R.P., Harms E., Strijland A., and Tager J.M. The intralysosomal pH in cultured human skin fibroblasts in relation to cystine accumulation in patients with cystinosis. Biochem. Biophys. Res. Commun. 116 (1983) 154-161
18. Jones D.P., Go Y.M., Anderson C.L., Ziegler T.R., Kinkade Jr. J.M., and Kirlin W.G. Cysteine/cystine couple is a newly recognized node in the circuitry for biologic redox signaling and control. FASEB J. 18 (2004) 1246-1248
19. F. Tietze, Enzymic reduction of cystine and other disulfides, in: J. Schulman (Ed.), Cystinosis, DHEW publication number (NIH) 72-249, 1973. US Government Printing Office.
20. Hengartner M. The biochemistry of apoptosis. Nature 407 (2000) 770-776
21. Guicciardi M., Denssing J., Miyoshi H., Bronk S., Svingen P.A., Peters C., Kaufmann S.H., and Gores G.J. Cathepsin B contributes to TNF-α-mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c. J. Clin. Invest. 106 (2000) 1127-1137
22. Kagedal K., Johansson U., and Ollinger K. The lysosomal protease cathepsin D mediates apoptosis by oxidative stress. FASEB J. 15 (2001) 1592-1594
23. Stoka V., Turk B., Schendel J., Kim T., Cirman T., Snipas S., Ellerby L., Bredesen D., Hudson F., Abrahamson M., Bromme D., Krajewski S., Reed J., Yin X., Turk V., and Salvesen G. Lysosomal pathways to apoptosis: Cleavage of BID not pro-caspases is the most likely route. J. Biol. Chem. 276 (2001) 3149-3157
24. Park M.A., Helip-Wooley A., and Thoene J.G. Lysosomal cystine storage augments apoptosis in cultured human fibroblasts and renal tubular epithelial cells. J. Am. Soc. Nephrol. 13 (2002) 2878-2887
25. Park M.A., and Thoene J.G. Potential role of apoptosis in development of the cystinotic phenotype. Pediatr. Nephrol. 20 (2005) 441-446
26. Park M., Pejovic V., Kerisit K., Junius S., and Thoene J. Increased apoptosis in cystinotic fibroblasts and renal proximal tubule epithelial cells results from cysteinylation of PKC δ. J. Am. Soc. Nephrol. 17 (2006) 3167-3175
27. Chu F., Ward N.E., and O′Brian C.A. PKC δ isozyme S-cysteinylation by cystine stimulates the pro-apoptotic isozyme PKC delta and inactivates the oncogenic isozyme PKC epsilon. Carcinogenesis 24 (2003) 317-325
28. Borner C., Ueffing M., Jaken S., Parker P.J., and Weinstein I.B. Two closely related isoforms of protein kinase C produce reciprocal effects on the growth of ratfibroblasts. Possible molecular mechanisms. J. Biol. Chem. 270 (1995) 78-86
29. Brodie C., and Blumberg P.M. Regulation of cell apoptosis by protein kinase C delta. Apoptosis 8 (2003) 19-27
30. Cross T., Griffiths G., Deacon E., Sallis R., Gough M., Watters D., and Lord J.M. PKC-δ is an apoptotic lamin kinase. Oncogene 19 (2000) 2331-2337
31. Darmady E., and Stranak F. Microdissection of the nephron in disease. British Med. Bull. 13 (1957) 21-26
32. Mahoney C., and Striker G. Early development of renal lesions in cystinosis. Pediatr. Nephrol. 15 (2000) 50-56
33. Najafian B., Kim Y., Crosson J., and Mauer M. Atubular glomeruli and glomerulotubular junction abnormalities in diabetic nephropathy. J. Am. Soc. Nephrol. 14 (2003) 908-917
34. M. Park, R. Nair, P. Walker, J. Thoene, The renal proximal tubule phenotype in cystinosis results from increased apoptosis. (Abstract) PAS 57 (2005), 1096.
35. Cherqui S., Sevin C., Hamard G., Kalatzis V., Sich M., Pequignot M.O., Gogat K., Abitbol M., Broyer M., Gubler M.C., and Antignac C. Intralysosomal cystine accumulation in mice lacking cystinosin, the protein defective in cystinosis. Mol. Cell Biol. 22 (2002) 7622-7632
36. Clipsham R., and McCabe E. DAX1 and its network partners: Exploring complexity in development. Mol. Genet. Metab. 80 (2003) 81-120
37. Dipple K.M., and McCabe E.R.B. Modifier genes convert "simple" Mendelian disorders to complex traits. Mol. Genet. Metab. 71 (2000) 43-50
38. Dipple K.M., and McCabe E.R.B. Phenotypes of patients with "simple" Mendelian disorders are complex traits: Threshholds, modifiers, and systems dynamics. Am. J. Hum. Genet. 66 (2000) 1729-1735
39. Dipple K.M., Phelan J.K., and McCabe E.R.B. Consequences of complexity within biological networks: Robustness and health, or vulnerability and disease. Mol. Genet. Metab. 74 (2001) 45-50
40. Scriver C.R., and Waters P.J. Monogenic traits are not simple: Lessons learned from phenylketonuria. Trends Genet. 15 (1999) 267-272
41. Langman C., Moore E., Thoene J., and Schneider J. Renal failure in a sibship with late-onset cystinosis. J. Pediatr. 107 (1985) 755-756